Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
roberta.costi@uniroma1.it
Roberta Costi
Professore Associato
Struttura:
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
E-mail:
roberta.costi@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors
PHARMACEUTICALS
2024
Quinolinonyl Derivatives as Dual Inhibitors of the HIV-1 Integrase Catalytic Site and Integrase-RNA interactions
ACS MEDICINAL CHEMISTRY LETTERS
2024
Inhibition of Leishmania infantum Trypanothione Reductase by New Aminopropanone Derivatives Interacting with the NADPH Binding Site
MOLECULES
2023
Pyrrolyl and indolyl α-γ-diketo acid derivatives acting as selective inhibitors of human carbonic anhydrases IX and XII
PHARMACEUTICALS
2023
Plants and Small Molecules: An Up-and-Coming Synergy
PLANTS
2023
Synergistic Effects of Caffeine in Combination with Conventional Drugs: Perspectives of a Drug That Never Ages
PHARMACEUTICALS
2023
Effects of Modified Glucosamine on the Chondrogenic Potential of Circulating Stem Cells under Experimental Inflammation
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication
ANTIVIRAL RESEARCH
2023
Role of a Novel Heparanase Inhibitor on the Balance between Apoptosis and Autophagy in U87 Human Glioblastoma Cells
CELLS
2023
Miconazole-like Scaffold is a Promising Lead for Naegleria fowleri-Specific CYP51 Inhibitors
JOURNAL OF MEDICINAL CHEMISTRY
2023
Oxidative stress and visual system a review
EXCLI JOURNAL
2022
The kinesin Eg5 inhibitor K858 exerts antiproliferative and proapoptotic effects and attenuates the invasive potential of head and neck squamous carcinoma cells
INVESTIGATIONAL NEW DRUGS
2022
Synthesis and evaluation of the antifungal and toxicological activity of Nitrofuran derivatives
PHARMACEUTICS
2022
Evaluation of the Anti-Histoplasma capsulatum activity of Indole and Nitrofuran derivatives and their pharmacological safety in three-dimensional cell cultures
PHARMACEUTICS
2022
Design, synthesis, and In vitro, in silico and in cellulo evaluation of new Pyrimidine and Pyridine amide and Carbamate derivatives as multi-functional Cholinesterase Inhibitors
PHARMACEUTICALS
2022
Exosomal Functional Cargoes from Liquid Biopsy of Gastric Cancer: A Systematic Review of Studies With Potential Clinical Relevance
ANTICANCER RESEARCH
2022
Ultrastructural damages to H1N1 influenza virus caused by vapor essential oils
MOLECULES
2022
New Inhibitors of the Human p300/CBP Acetyltransferase Are Selectively Active against the Arabidopsis HAC Proteins
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
Exosomal Functional Cargoes from Liquid Biopsy of Gastric Cancer: A Systematic Review of Studies With Potential Clinical Relevance
ANTICANCER RESEARCH
2022
Acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease–a patent review (2016–present)
EXPERT OPINION ON THERAPEUTIC PATENTS
2021
1
2
3
4
seguente ›
ultima »
Progetti di Ricerca
Development of Inhibitors Targeting CoronaViruses-related diseases
Design and Development of novel Heparanase inhibitors able to modulate autophagy
Novel selective inhibitors of ribonuclease H function of the HIV-1 reverse transcriptase enzyme
Innovative small molecules as inhibitors of ribonuclease H function of the HIV-1 reverse transcriptase enzyme
Targeting poverty-related co-infectious diseases through drug lead optimization and combination studies
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma